Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History LUNG

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics LUNG

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Pulmonx Corp

LUNG
Current price
3.15 USD -0.05 USD (-1.56%)
Last closed 3.09 USD
ISIN US7458481014
Sector Healthcare
Industry Medical Devices
Exchange NASDAQ
Capitalization 126 811 128 USD
Yield for 12 month -62.32 %
1Y
3Y
5Y
10Y
15Y
LUNG
21.11.2021 - 28.11.2021

Pulmonx Corporation, a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease. It offers Zephyr Endobronchial Valve; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. The company also offers LungTraX Platform, a cloud-based quantitative computed tomography analysis service that provides physicians with multiple products, such as LungTraX Connect to improve workup efficiency; LungTraX Detect to enable patient identification; and StratX Lung report that is designed for solution that includes information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for treatment with Zephyr Valves. It serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California. Address: 700 Chesapeake Drive, Redwood City, CA, United States, 94063

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

11.31 USD

P/E Ratio

Dividend Yield

Financials LUNG

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures LUNG

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

+83 789 000 USD

Last Year

+68 675 000 USD

Current Quarter

+22 538 000 USD

Last Quarter

+23 765 000 USD

Current Year

+62 001 000 USD

Last Year

+50 752 000 USD

Current Quarter

+16 342 000 USD

Last Quarter

+17 690 000 USD
EBITDA -54 666 000 USD
Operating Margin TTM -64.62 %
Price to Earnings
Return On Assets TTM -22.21 %
PEG Ratio
Return On Equity TTM -60.68 %
Wall Street Target Price 11.31 USD
Revenue TTM 87 473 000 USD
Book Value 1.93 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 19.50 %
Dividend Yield
Gross Profit TTM 64 265 000 USD
Earnings per share -1.44 USD
Diluted Eps TTM -1.44 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin -65.27 %

Stock Valuation LUNG

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 28.33
Enterprise Value Revenue 1.09
Price Sales TTM 1.45
Enterprise Value EBITDA -5.62
Price Book MRQ 1.63

Technical Indicators LUNG

For 52 Weeks

2.50 USD 9.37 USD
50 Day MA 3.08 USD
Shares Short Prior Month 1 417 346
200 Day MA 5.78 USD
Short Ratio 3.78
Shares Short 1 318 828
Short Percent 5.19 %